Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Disclosed are methods to treat patients with AFib by monitoring their heart rhythm to determine the presence and/or the number of episodes of long duration AFib, and optionally the extent of AFib burden. Patients who meet threshold requirements are qualified for the treatment of AFib with a dosage o...

Full description

Saved in:
Bibliographic Details
Main Authors Milner, Peter Gerard, Druzgala, Pascal
Format Patent
LanguageEnglish
Published 12.12.2023
Subjects
DIAGNOSIS
ELECTROTHERAPY
HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
PHYSICS
RADIATION THERAPY
SURGERY
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:Disclosed are methods to treat patients with AFib by monitoring their heart rhythm to determine the presence and/or the number of episodes of long duration AFib, and optionally the extent of AFib burden. Patients who meet threshold requirements are qualified for the treatment of AFib with a dosage of budiodarone. Patient monitoring is continued in order confirm that the patient is and remains responsive to budiodarone therapy including dose adjusting the patient to achieve such therapy. Subsequently, monitoring is continued to confirm that the patient remains responsive. These methods allow for treatment of the AFib and, correspondingly, reduce or delay the risk of stroke and/or congestive heart failure in the treated patient.
Bibliography:Application Number: US202318123093